KR20120023633A - 허혈 및 당뇨병 상처 치유를 촉진하기 위한 조성물, 키트 및 방법 - Google Patents

허혈 및 당뇨병 상처 치유를 촉진하기 위한 조성물, 키트 및 방법 Download PDF

Info

Publication number
KR20120023633A
KR20120023633A KR1020117026193A KR20117026193A KR20120023633A KR 20120023633 A KR20120023633 A KR 20120023633A KR 1020117026193 A KR1020117026193 A KR 1020117026193A KR 20117026193 A KR20117026193 A KR 20117026193A KR 20120023633 A KR20120023633 A KR 20120023633A
Authority
KR
South Korea
Prior art keywords
selectin
wound
sdf
protein
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
KR1020117026193A
Other languages
English (en)
Korean (ko)
Inventor
오마이다 씨. 벨라즈퀘즈
자오-쥰 리우
Original Assignee
유니버시티 오브 마이애미
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 유니버시티 오브 마이애미 filed Critical 유니버시티 오브 마이애미
Publication of KR20120023633A publication Critical patent/KR20120023633A/ko
Abandoned legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/7056—Lectin superfamily, e.g. CD23, CD72
    • C07K14/70564—Selectins, e.g. CD62
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/195—Chemokines, e.g. RANTES
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Physiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
KR1020117026193A 2009-04-21 2010-04-09 허혈 및 당뇨병 상처 치유를 촉진하기 위한 조성물, 키트 및 방법 Abandoned KR20120023633A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17127109P 2009-04-21 2009-04-21
US61/171,271 2009-04-21

Publications (1)

Publication Number Publication Date
KR20120023633A true KR20120023633A (ko) 2012-03-13

Family

ID=43011688

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020117026193A Abandoned KR20120023633A (ko) 2009-04-21 2010-04-09 허혈 및 당뇨병 상처 치유를 촉진하기 위한 조성물, 키트 및 방법

Country Status (6)

Country Link
US (1) US20120058086A1 (https=)
EP (1) EP2421967A4 (https=)
JP (1) JP2012524781A (https=)
KR (1) KR20120023633A (https=)
CN (1) CN102421894A (https=)
WO (1) WO2010123699A2 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016516071A (ja) * 2013-03-15 2016-06-02 ユベンタス セラピューティクス，インコーポレイテッド 瘢痕形成を軽減するためのｓｄｆ−１の使用
EP3237622B1 (en) * 2014-12-23 2021-02-24 Ilya Pharma AB Methods for wound healing
WO2016149632A1 (en) * 2015-03-18 2016-09-22 Bio1 Systems, Llc Digital wound assessment device and method
CN106581068A (zh) * 2016-11-08 2017-04-26 广州医科大学附属第三医院 一种可以快速恢复皮肤创面的生物膜及其制备方法
CN110769861A (zh) * 2017-05-02 2020-02-07 迈阿密大学 治疗缺血性组织的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070244043A1 (en) * 2005-03-10 2007-10-18 Novavax, Inc. Recombinant E-selectin made in insect cells
US8440617B2 (en) * 2007-03-22 2013-05-14 The Trustees Of The University Of Pennsylvania Hyperbaric treatment in wound healing

Also Published As

Publication number Publication date
EP2421967A2 (en) 2012-02-29
WO2010123699A2 (en) 2010-10-28
EP2421967A4 (en) 2013-01-02
JP2012524781A (ja) 2012-10-18
WO2010123699A3 (en) 2011-01-06
US20120058086A1 (en) 2012-03-08
CN102421894A (zh) 2012-04-18

Similar Documents

Publication Publication Date Title
CA2504019C (en) Stromal cell-derived factor-1 mediates stem cell homing and tissue regeneration in ischemic cardiomyopathy
Gharaibeh et al. Biological approaches to improve skeletal muscle healing after injury and disease
US20040161412A1 (en) Cell-based VEGF delivery
US20150139952A1 (en) Methods, compositions, cells, and kits for treating ischemic injury
ES2520044T3 (es) SDF-1 para su uso en el tratamiento de trastornos vasculares periféricos isquémicos
US20040131601A1 (en) Injection of bone marrow-derived cells and medium for angiogenesis
KR20120023633A (ko) 허혈 및 당뇨병 상처 치유를 촉진하기 위한 조성물, 키트 및 방법
JP2018533922A (ja) 心臓傷害を処置するための方法
Wu et al. MG53 binding to CAV3 facilitates activation of eNOS/NO signaling pathway to enhance the therapeutic benefits of bone marrow-derived mesenchymal stem cells in diabetic wound healing
JP7450244B2 (ja) 虚血組織を治療するための方法
US20160193290A1 (en) Methods of Reducing Myocardial Injury Following Myocardial Infarction
US20220280607A1 (en) Treatment of Heart Defects and Conditions in Pediatric Patients
US20060051334A1 (en) Injection of bone marrow-derived conditioned medium for angiogenesis
US20030148952A1 (en) Methods and materials for the recruitment of endothelial cells
US20240238346A1 (en) Myocardial wound healing post ischemic injury
AU2010241483B2 (en) Stromal cell-derived factor-1 mediates stem cell homing and tissue regeneration
Merentie Cardiological studies in mice: special emphasis on gene therapy, imaging and ECG findings
JP2006519873A (ja) 血管形成を促進するための腫瘍内皮マーカー１、９、および１７の使用

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20111103

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20150409

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20160303

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20170125

NORF Unpaid initial registration fee
PC1904 Unpaid initial registration fee